Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection

Abstract

Filgrastim was safe and effective in preventing severe neutropenia in patients with advanced HIV infection, and may reduce the incidence and duration of bacterial infections, incidence of severe bacterial infections, duration of hospital days for infections, and days of intravenous antibacterial agents.